20th Salute to Excellence Awards Gala 2018Gala/Party for American Liver Foundation
Apr 21, 2018 from 6:00 PM to 9:30 PM
The American Liver Foundation’s Salute to Excellence Awards Gala and request your participation as a 2018 auction sponsor. Celebrating 19 years, this black tie event will take place at the historic Fairmont San Francisco on Saturday, April 21, 2018. Our goal is to raise $250,000 to fund liver research and increase awareness of liver health through support, education, and advocacy.
The Salute to Excellence Gala recognizes individuals in the Bay Area who have made an outstanding contribution to the fields of biotechnology, medicine and business/philanthropy. This year we are proud to honor David Beier, JD, Managing Director, Bay City Capital, Stewart Cooper, MD, Chief, Division of Hepatology, Director of Research & Kalmanovitz Liver Immunology Laboratory, California Pacific Medical Center, and Gregg Alton, Executive Vice President, Corporate and Medical Affairs, Gilead Sciences, Inc.
ALF’s Gala is a most visible social event and hosts more than 250 local notables, influential supporters, doctors, medical professionals, strategic partners and business leaders in the healthcare and biotech industries. Sponsors and their guests will enjoy a VIP reception with the Honorees in the historic Pavilion Room, then join a cocktail reception with the rest of the guests followed by an elegant 3-course dinner in the Venetian Ballroom. A silent auction sporting exciting surprises and a Dream Vacation drawing rounds out a wonderful gala ending in a stunning awards presentation to the 2017 Honorees. The Salute to Excellence Awards Gala has raised more than $4 million to benefit the American Liver Foundation.
Founded in 1976, the American Liver Foundation, a nationwide network of staff and volunteers whose mission is to facilitate, advocate and provide awareness, outreach, education and patient support services to the public about liver health. We are a trusted voice for all patients and their families living with liver disease.Thirty million Americans, or 1 in 10, are affected by over 100 types of liver disease; about 25% of Americans – including 10% of school-aged kids have non-alcoholic fatty liver disease. It can be inherited or develop later in life. It does not discriminate. It affects individuals without consideration for age, gender, ethnicity, or socioeconomic status. Liver disease is the 12th leading cause of death in the U.S. and takes approximately 27,000 lives each year.
950 Mason St.
San Francisco, CA 94108